In today’s biologics drug development landscape, flexible, end-to-end solutions are crucial for advancing candidates efficiently. This session will showcase our integrated modular services, spanning antibody discovery, protein engineering, production, and in vitro/in vivo testing, all designed to streamline biologics research. We’ll highlight our expertise in providing tailored services for each stage of antibody drug development - from monoclonal to bispecific antibodies, high-throughput small-scale production, to scale-up processes. Through case studies, we will demonstrate how our innovative solutions set new standards in quality and speed, helping clients select the best candidates to advance to CMC.